Futura Medical plc (FAMDF)

USD 0.38

(0.0%)

Revenue Summary of Futura Medical plc

  • Futura Medical plc's latest annual revenue in 2023 was 3.1 Million GBP , down 0.0% from previous year.
  • Futura Medical plc's latest quarterly revenue in 2024 Q1 was 3.5 Million GBP , up 400.94% from previous quarter.
  • Futura Medical plc reported a annual revenue of - GBP in annual revenue 2022, down 0.0% from previous year.
  • Futura Medical plc reported a annual revenue of - GBP in annual revenue 2021, down 0.0% from previous year.
  • Futura Medical plc reported a quarterly revenue of 3.5 Million GBP for 2024 Q1, up 400.94% from previous quarter.
  • Futura Medical plc reported a quarterly revenue of 851.72 Thousand GBP for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of Futura Medical plc (2023 - 2000)

Historical Annual Revenue of Futura Medical plc (2023 - 2000)

Year Revenue Revenue Growth
2023 3.1 Million GBP 0.0%
2022 - GBP 0.0%
2021 - GBP 0.0%
2020 - GBP -100.0%
2019 31.77 Thousand GBP 0.0%
2018 - GBP -100.0%
2017 362.72 Thousand GBP 112.92%
2016 170.36 Thousand GBP 477.97%
2015 29.47 Thousand GBP -32.9%
2014 43.92 Thousand GBP -88.16%
2013 370.9 Thousand GBP 394.54%
2012 75 Thousand GBP -52.53%
2011 158 Thousand GBP 26.4%
2010 125 Thousand GBP 150.0%
2009 50 Thousand GBP -66.67%
2008 150 Thousand GBP 900.0%
2007 15 Thousand GBP 0.0%
2006 - GBP -100.0%
2005 2000.00 GBP -98.46%
2004 130 Thousand GBP 0.0%
2003 - GBP 0.0%
2002 - GBP 0.0%
2001 - GBP 0.0%
2000 - GBP 0.0%

Peer Revenue Comparison of Futura Medical plc

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 80.34%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -17498.139%
SQZ Biotechnologies Company 21.47 Million USD 85.562%
Evofem Biosciences, Inc. 18.21 Million USD 82.979%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 97.478%
Mesoblast Limited 5.9 Million USD 47.459%
Propanc Biopharma, Inc. - USD -Infinity%
Genus plc 668.8 Million USD 99.536%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -656.029%
Marizyme, Inc. 645.81 Thousand USD -380.167%
ContraFect Corporation - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -3939.77%
Intellipharmaceutics International Inc. 65.72 Thousand USD -4617.88%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -7746.976%
MultiCell Technologies, Inc. 49.32 USD -6287345.255%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 93.763%
EV Biologics, Inc. 48.9 Thousand USD -6241.448%
Q BioMed Inc. 284.35 Thousand USD -990.538%
Emmaus Life Sciences, Inc. 29.59 Million USD 89.523%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 98.736%
Oncotelic Therapeutics, Inc. 70 Thousand USD -4329.954%
Skye Bioscience, Inc. - USD -Infinity%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -3032.481%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -3995.093%
IMV Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -370.914%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.979%
Halberd Corporation 999.00 USD -310307.207%
Enzolytics Inc. 52.79 Thousand USD -5773.49%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. 1.36 Million USD -126.513%
SYBLEU INC 11.69 Thousand USD -26413.064%
Nuo Therapeutics, Inc. 608.52 Thousand USD -409.588%
argenx SE 1.22 Billion USD 99.747%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD -60.506%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -402.275%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.631%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 97.863%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -456.018%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -210.804%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 93.587%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 16.68 Million USD 81.415%
ONE Bio Corp. 52.29 Million USD 94.07%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -1210.859%
Regen BioPharma, Inc. 236.56 Thousand USD -1210.859%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -2111.155%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -554.586%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 60.188%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -23753.6%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -7743.8%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 6.878%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 53.474%
IntelGenx Technologies Corp. 1.03 Million USD -198.457%
Gelesis Holdings, Inc. 25.76 Million USD 87.965%
CSL Limited 14.8 Billion USD 99.979%
Cellectis S.A. 755 Thousand USD -310.724%